Successful treatment of X-linked sideroblastic anemia with <i>ALAS2</i> R452H mutation using vitamin B<sub>6</sub>

  • KAWAKAMI Toru
    Division of Hematology, Department of Internal Medicine, Shinshu University School of Medicine
  • NAKAZAWA Hideyuki
    Division of Hematology, Department of Internal Medicine, Shinshu University School of Medicine
  • KAWAKAMI Fumihiro
    Division of Hematology, Department of Internal Medicine, Shinshu University School of Medicine
  • MATSUZAWA Shuji
    Division of Hematology, Department of Internal Medicine, Shinshu University School of Medicine
  • SUDO Yuriko
    Division of Hematology, Department of Internal Medicine, Shinshu University School of Medicine
  • SAKAI Hitoshi
    Division of Hematology, Department of Internal Medicine, Shinshu University School of Medicine
  • NISHINA Sayaka
    Division of Hematology, Department of Internal Medicine, Shinshu University School of Medicine
  • SENOO Noriko
    Division of Hematology, Department of Internal Medicine, Shinshu University School of Medicine
  • SENOO Yasushi
    Division of Hematology, Department of Internal Medicine, Shinshu University School of Medicine
  • KOMATSU Michiharu
    Division of Gastroenterology, Department of Internal Medicine, Shinshu University School of Medicine
  • UMEMURA Takeji
    Division of Gastroenterology, Department of Internal Medicine, Shinshu University School of Medicine
  • YAMAGUCHI Tomomi
    Center for Medical Genetics, Shinshu University Hospital
  • KOSHO Tomoki
    Center for Medical Genetics, Shinshu University Hospital
  • FUJIWARA Tohru
    Department of Hematology and Rheumatology, Tohoku University Graduate School of Medicine
  • HARIGAE Hideo
    Department of Hematology and Rheumatology, Tohoku University Graduate School of Medicine
  • ISHIDA Fumihiro
    Division of Hematology, Department of Internal Medicine, Shinshu University School of Medicine Department of Biomedical Laboratory Science, Shinshu University School of Medicine

Bibliographic Information

Other Title
  • ビタミンB<sub>6</sub>が著効した<i>ALAS2</i> R452H変異陽性X連鎖性鉄芽球性貧血
  • 症例報告 第7回日本血液学会関東甲信越地方会 優秀演題 ビタミンB₆が著効したALAS2 R452H変異陽性X連鎖性鉄芽球性貧血
  • ショウレイ ホウコク ダイ7カイ ニホン ケツエキ ガッカイ カントウ コウシンエツチホウカイ ユウシュウ エンダイ ビタミン B ₆ ガ チョコウシタ ALAS2 R452H ヘンイ ヨウセイ X レンサセイテツ ガキュウセイ ヒンケツ

Search this article

Abstract

<p>A 45-year-old man presented with fatigue and pain in the finger joints. Despite having a history of suspected sideroblastic anemia since the age of 18 years, he had not been followed up for years. Upon presentation, laboratory data revealed microcytic anemia and elevated serum ferritin levels. In addition, ringed sideroblasts were increased in the bone marrow. A liver biopsy revealed hemochromatosis and cirrhosis. Furthermore, genetic analysis revealed that he harbored the ALAS2 R452H mutation, leading to the diagnosis of X-linked sideroblastic anemia (XLSA). Accordingly, oral folate or vitamin (Vit) B12 was administered, but his anemia did not respond. However, his hemoglobin level increased from 7 to 11 g/dl with an additional prescription of oral VitB6, which facilitated the patient to undergo phlebotomy to ameliorate organ dysfunctions caused by iron overload. Previous research has revealed that ALAS2 R452 mutations confer poor responses to VitB6 therapy. Hence, accrual of patients with an unexpectedly better response, which was observed in our case, may help elucidate the pathogenesis of and therapies for XLSA.</p>

Journal

  • Rinsho Ketsueki

    Rinsho Ketsueki 59 (4), 401-406, 2018

    The Japanese Society of Hematology

Related Projects

See more

Details 詳細情報について

Report a problem

Back to top